Risk factors for nosocomial rectal colonisation with carbapenem-resistant Gram-negative bacilli in children with haematological malignancies: a case-control study

被引:2
|
作者
Fang, Chao [1 ]
Zhou, Zheng [1 ]
Zhou, Mingming [1 ]
Li, Jianping [1 ]
机构
[1] Zhejiang Univ, Childrens Hosp, Sch Med, Natl Clin Res Ctr Child Hlth,Dept Clin Lab, 3333 Binsheng Rd, Hangzhou, Zhejiang, Peoples R China
关键词
Carbapenem-resistant Enterobacteriaceae; Intestines; Colonisation; Risk factors; Haematologic neoplasms; Child; Case-control studies; CELL TRANSPLANT RECIPIENTS; ENTEROBACTERIACEAE; INFECTION; ORGANISMS;
D O I
10.1186/s12941-023-00622-x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
BackgroundRectal colonisation with carbapenem-resistant Gram-negative bacilli (CR-GNB) may cause CR-GNB infection in children with haematological malignancies (HMs) haematological. To date, information on its epidemiology is limited. This study aimed to assess the the risk factors for rectal colonisation with CR-GNB in children with HMs.MethodsA case-control study in a tertiary children's hospital in Hangzhou City, was conducted between July 2019, and September 2021. Based on the hospitalisation date, children in the CR-GNB colonisation group and control groups were matched at a ratio of 1:2. Conditional logistic regression models were used to compute the adjusted odds ratios (aORs) and 95% confidence intervals (CIs) of the risk factors for CR-GNB rectal colonisation in children with HMs.ResultsA total of 85 non-duplicated CR-GNB isolates were collected from rectal swab samples of 69 children with HMs. The 30-day mortality rates were 5.8% in the CR-GNB colonisation group and 0% in the control group (P = 0.020).colonisation In the conditional logistic regression model, the aORs were 6.84 (95% CI 1.86-25.20) for acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL), 4.16 (95% CI 1.17-14.84) for prior concomitant infections within the last 1 month, 2.33 (95% CI 1.16-4.69) for prior carbapenems usage within the last 1 month and 7.46 (95% CI 1.81-30.67) for prior hematopoietic stem-cell transplantation (HSCT).ConclusionAML/ALL, prior concomitant infections within the last 1 month, prior carbapenems usage within the last 1 month, and prior HSCT are associated with an increased risk of rectal colonisation with CR-GNB in children with HMs.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Risk factors for Carbapenem-resistant Enterobacterales infections: A case-control study
    Mbele, Sibongakonke
    Vasaikar, Sandeep D.
    SOUTH AFRICAN FAMILY PRACTICE, 2025, 67 (01)
  • [22] Carbapenem-resistant Gram-negative bacilli in Canada 200910: results from the Canadian Nosocomial Infection Surveillance Program (CNISP)
    Mataseje, L. F.
    Bryce, E.
    Roscoe, D.
    Boyd, D. A.
    Embree, J.
    Gravel, D.
    Katz, K.
    Kibsey, P.
    Kuhn, M.
    Mounchili, A.
    Simor, A.
    Taylor, G.
    Thomas, E.
    Turgeon, N.
    Mulvey, M. R.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (06) : 1359 - 1367
  • [23] Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study
    Ting, Shih-Wen
    Lee, Chen-Hsiang
    Liu, Jien-Wei
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2018, 51 (05) : 621 - 628
  • [24] Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients
    Routsi, Christina
    Pratikaki, Maria
    Platsouka, Evangelia
    Sotiropoulou, Christina
    Papas, Vasileios
    Pitsiolis, Theodoros
    Tsakris, Athanassios
    Nanas, Serafeim
    Roussos, Charis
    INTENSIVE CARE MEDICINE, 2013, 39 (07) : 1253 - 1261
  • [25] Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients
    Christina Routsi
    Maria Pratikaki
    Evangelia Platsouka
    Christina Sotiropoulou
    Vasileios Papas
    Theodoros Pitsiolis
    Athanassios Tsakris
    Serafeim Nanas
    Charis Roussos
    Intensive Care Medicine, 2013, 39 : 1253 - 1261
  • [26] Synergistic antibacterial activity of silver nanoparticles biosynthesized by carbapenem-resistant Gram-negative bacilli
    Sayran Hamad Haji
    Fattma A. Ali
    Safaa Toma Hanna Aka
    Scientific Reports, 12
  • [27] Carbapenemase Detection among Carbapenem-Resistant Glucose-Nonfermenting Gram-Negative Bacilli
    Simner, Patricia J.
    Opene, Belita N. A.
    Chambers, Krizia K.
    Naumann, Matthew E.
    Carroll, Karen C.
    Tamma, Pranita D.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2017, 55 (09) : 2858 - 2864
  • [28] Synergistic antibacterial activity of silver nanoparticles biosynthesized by carbapenem-resistant Gram-negative bacilli
    Haji, Sayran Hamad
    Ali, Fattma A.
    Aka, Safaa Toma Hanna
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [29] International guidelines for the treatment of carbapenem-resistant Gram-negative Bacilli infections: A comparison and evaluation
    Wang, Chuhui
    Bai, Chuqi
    Chen, Keyu
    Du, Qian
    Cheng, Shiqi
    Zeng, Xiaoyan
    Wang, Yan
    Dong, Yalin
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (05)
  • [30] Characteristics of Carbapenem-Resistant Gram-Negative Bacilli in Patients with Ventilator-Associated Pneumonia
    Mohamed, Amira
    Daef, Enas
    Nafie, Amany
    Shaban, Lamia
    Ibrahim, Maggie
    ANTIBIOTICS-BASEL, 2021, 10 (11):